Dorsch D - Search Results

1

Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors.

Dorsch D, Schadt O, Stieber F, Meyring M, Grädler U, Bladt F, Friese-Hamim M, Knühl C, Pehl U, Blaukat A. Dorsch D, et al. Bioorg Med Chem Lett. 2015 Apr 1;25(7):1597-602. doi: 10.1016/j.bmcl.2015.02.002. Epub 2015 Feb 16. Bioorg Med Chem Lett. 2015. PMID: 25736998

2

Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives.

Mederski WW, Dorsch D, Bokel HH, Beier N, Lues I, Schelling P. Mederski WW, et al. Among authors: dorsch d. J Med Chem. 1994 May 27;37(11):1632-45. doi: 10.1021/jm00037a014. J Med Chem. 1994. PMID: 8201597

3

Endothelin antagonists: search for surrogates of methylendioxyphenyl by means of a Kohonen neural network.

Anzali S, Mederski WW, Osswald M, Dorsch D. Anzali S, et al. Among authors: dorsch d. Bioorg Med Chem Lett. 1998 Jan 6;8(1):11-6. doi: 10.1016/s0960-894x(97)10150-0. Bioorg Med Chem Lett. 1998. PMID: 9871620

4

Endothelin antagonists: evaluation of 2,1,3-benzothiadiazole as a methylendioxyphenyl bioisoster.

Mederski WW, Osswald M, Dorsch D, Anzali S, Christadler M, Schmitges CJ, Wilm C. Mederski WW, et al. Among authors: dorsch d. Bioorg Med Chem Lett. 1998 Jan 6;8(1):17-22. doi: 10.1016/s0960-894x(97)10151-2. Bioorg Med Chem Lett. 1998. PMID: 9871621

5

Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist.

Mederski WW, Dorsch D, Osswald M, Anzali S, Christadler M, Schmitges CJ, Schelling P, Wilm C, Fluck M. Mederski WW, et al. Among authors: dorsch d. Bioorg Med Chem Lett. 1998 Jul 7;8(13):1771-6. doi: 10.1016/s0960-894x(98)00301-1. Bioorg Med Chem Lett. 1998. PMID: 9873432

6

Benzofuro[3,2-b]pyridines as mixed ET(A)/ET(B) and selective ET(B) endothelin receptor antagonists.

Mederski WW, Osswald M, Dorsch D, Christadler M, Schmitges CJ, Wilm C. Mederski WW, et al. Among authors: dorsch d. Bioorg Med Chem Lett. 1999 Feb 22;9(4):619-22. doi: 10.1016/s0960-894x(99)00040-2. Bioorg Med Chem Lett. 1999. PMID: 10098676

7

Halothiophene benzimidazoles as P1 surrogates of inhibitors of blood coagulation factor Xa.

Mederski WW, Dorsch D, Anzali S, Gleitz J, Cezanne B, Tsaklakidis C. Mederski WW, et al. Among authors: dorsch d. Bioorg Med Chem Lett. 2004 Jul 16;14(14):3763-9. doi: 10.1016/j.bmcl.2004.04.097. Bioorg Med Chem Lett. 2004. PMID: 15203158

8

Chlorothiophenecarboxamides as P1 surrogates of inhibitors of blood coagulation factor Xa.

Mederski WW, Cezanne B, van Amsterdam C, Bühring KU, Dorsch D, Gleitz J, März J, Tsaklakidis C. Mederski WW, et al. Among authors: dorsch d. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5817-22. doi: 10.1016/j.bmcl.2004.09.043. Bioorg Med Chem Lett. 2004. PMID: 15501047

9

Rapid preparation of triazolyl substituted NH-heterocyclic kinase inhibitors via one-pot Sonogashira coupling-TMS-deprotection-CuAAC sequence.

Merkul E, Klukas F, Dorsch D, Grädler U, Greiner HE, Müller TJ. Merkul E, et al. Among authors: dorsch d. Org Biomol Chem. 2011 Jul 21;9(14):5129-36. doi: 10.1039/c1ob05586k. Epub 2011 May 31. Org Biomol Chem. 2011. PMID: 21625704

10

EMD 1214063 and EMD 1204831 constitute a new class of potent and highly selective c-Met inhibitors.

Bladt F, Faden B, Friese-Hamim M, Knuehl C, Wilm C, Fittschen C, Grädler U, Meyring M, Dorsch D, Jaehrling F, Pehl U, Stieber F, Schadt O, Blaukat A. Bladt F, et al. Among authors: dorsch d. Clin Cancer Res. 2013 Jun 1;19(11):2941-51. doi: 10.1158/1078-0432.CCR-12-3247. Epub 2013 Apr 3. Clin Cancer Res. 2013. PMID: 23553846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters